Related Experiment Video

Updated: Aug 15, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Modulatory effect of 8-iso-PGE2 on platelets

G Kobzar1, V Mardla, I Järving

  • 1Institute of Chemistry, EE0026 Tallinn, Estonia.

General Pharmacology
|February 1, 1997
PubMed

Insights

8-Isoprostane E2 (8-Iso-PGE2) can alter platelet aggregation, sometimes causing it directly or modifying responses to other agents like ADP and adrenaline. Its effects vary, potentially amplifying or weakening platelet activity depending on concentration and agent.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Hematology

Background:

  • Platelet aggregation is crucial for hemostasis and thrombosis.
  • Prostaglandin E2 (PGE2) and its analogs play roles in platelet function.
  • The specific effects of 8-isoprostane E2 (8-Iso-PGE2) on platelet aggregation require further elucidation.

Purpose of the Study:

  • To investigate the direct effects of 8-Iso-PGE2 on platelet aggregation.
  • To determine how 8-Iso-PGE2 modulates platelet aggregation induced by other agonists.
  • To compare the effects of 8-Iso-PGE2 in human and rabbit platelet models.

Main Methods:

  • Platelet-rich plasma (PRP) and washed platelets (WP) from humans and rabbits were used.
  • Platelet aggregation was induced by 8-Iso-PGE2 alone or in combination with adenosine diphosphate (ADP), adrenaline, or platelet-activating factor (PAF).
  • Dose-response relationships and EC50 values for aggregation were determined.

Main Results:

  • 8-Iso-PGE2 induced reversible or irreversible platelet aggregation in human PRP and WP.
  • In rabbits, 8-Iso-PGE2 primarily induced reversible aggregation or had no effect.
  • 8-Iso-PGE2 potentiated ADP-induced aggregation in both species and adrenaline-induced aggregation in rabbits.
  • Effects on PAF-induced aggregation were concentration-dependent in humans (low doses decreased, high doses increased) and consistently decreased in rabbits.

Conclusions:

  • 8-Iso-PGE2 exhibits complex effects on platelet aggregation.
  • Low concentrations of 8-Iso-PGE2 can modulate platelet responses to various agonists.
  • These findings highlight the potential role of 8-Iso-PGE2 in regulating platelet activity.

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...